Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:11:57.341Z.
Calculation as of: 2026-10-06T15:11:57.341Z.
Quote observation: 2026-10-06T15:10:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f97479f440d7a03605f533a56e26179237db48e588053495707f458dff3bcd44
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$5.06B
Free Cash Flow Yield
4.02%
TTM Avg
3.85%
3Y Avg
2.74%
5Y Avg
2.55%
Market Cap
$4.90B
Free Cash Flow Yield
N/A
TTM Avg
1.04%
3Y Avg
1.04%
5Y Avg
1.04%
Market Cap
$5.21B
Free Cash Flow Yield
N/A
TTM Avg
3.62%
3Y Avg
3.62%
5Y Avg
3.62%
Market Cap
$4.86B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.81B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.24B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.29B
Free Cash Flow Yield
N/A
TTM Avg
8.07%
3Y Avg
4.52%
5Y Avg
4.52%
Market Cap
$5.36B
Free Cash Flow Yield
5.58%
TTM Avg
5.52%
3Y Avg
3.51%
5Y Avg
2.87%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Erasca, Inc. (ERAS) | $5.02B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.06B | 4.02% | 3.85% | 2.74% | 2.55% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | N/A | 1.04% | 1.04% | 1.04% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.21B | N/A | 3.62% | 3.62% | 3.62% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.86B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.81B | N/A | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.24B | N/A | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.29B | N/A | 8.07% | 4.52% | 4.52% |
| Doximity, Inc. (DOCS)vs › | $5.36B | 5.58% | 5.52% | 3.51% | 2.87% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
